International Chemical Investors Group
  • HOME
  • OUR APPROACH
  • OUR INVESTMENTS
    • Market Oriented Platforms
    • Companies
  • NEWS
  • CONTACT

ICIG announces the appointment of Dr. Michael Quirmbach as CEO & President of CordenPharma Group

by Infrastructure Support | Jul 26, 2019 | News

26. July 2019 CordenPharma Group, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is pleased to announce the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective...

LATEST ICIG NEWS

New production facility for aromatic ring chlorination in Frankfurt-Höchst

On November 26th, Dr. Uwe Brunk, President of WeylChem Group of Companies (WCGC), announced the larger scale investment in a new production facility for aromatic ring...

CordenPharma Increases Centre of Excellence for Peptide Development Capacity to Support European Domestic Growth

Luxembourg, 17. November 2020 CordenPharma’s Centre of Excellence for Peptide Process Development and non-GMP manufacturing in Frankfurt, Germany is not only known for...

Vynova pioneers production of circular-attributed PVC

12 November 2020 Vynova has launched the world’s first range of certified circular-attributed PVC resins. The innovative PVC portfolio is manufactured using circular...

Vynova partners with digital marketplace Knowde to strengthen online presence and e-marketing efforts

28 September 2020 Vynova, a leading European PVC and chlor-alkali producer, has opened a storefront on Knowde, the world's premier e-commerce site for chemicals,...

⤏ All News